Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile
Advanced Prostate Cancer Consensus Conference

@apccc_lugano

APCCC facilitates discussions and debates on advanced prostate cancer diagnostic and treatment options.

ID: 2192533356

linkhttps://apccc.org calendar_today13-11-2013 16:03:59

10,10K Tweet

4,4K Followers

712 Following

Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile Photo
Advanced Prostate Cancer Consensus Conference
@apccc_lugano

3 months ago

Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study annalsofoncology.org/article/S0923-… The phase III

Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study annalsofoncology.org/article/S0923-… The phase III